Pharmaceutical product overview
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Epilepsy |  |
692 |
-4% |
| Alzheimer's disease |  |
632 |
20% |
| Epilepsy |  |
413 |
6% |
| Parkinson's disease |  |
420 |
24% |
| Attention deficit disorder | Ritalin
|
375 |
14% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Hypertension |   |
5012 |
19% |
| Hypertension |  |
748 |
-45% |
| Cholesterol reduction |  |
665 |
-8% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Asthma |  |
362 |
9% |
| Cystic Fibrosis | Tobramycin |
273 |
54% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Transplantation |  |
944 |
3% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Chronic myeloid leukemia |  |
3050 |
19% |
| Cancer complications |  |
1297 |
1% |
| Acromegaly |  |
1027 |
12% |
| Breast cancer |  |
937 |
30% |
| Iron chelator |  |
357 |
150% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD | Inflammation / pain |  |
747 |
8% |
| Osteoporosis |  |
281 |
-17% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Fungal infections |  |
595 |
-39% |
| Indication | Product | Full Year 2007 Sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Age-related macular degeneration |  |
393 |
NM* |
| NM = Not Meaningful | |||
Quarterly results
View and download the latest quarterly reports from Novartis.
Corporate publications
